Tekla Life Sciences Investors
HQL
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technolā¦ read more
Financial Services
Asset Management
31 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$13.09
Price+0.08%
$0.01
1Y
Price
Market Cap
$377.940m
Small
Price/Earnings 3y Avg5y Avg
3.3x
Premium
Premium
Dividends
Ex-Dividend: May 22, 2513.14%
Yield$1.72
Dividend0.00%
Forward Dividend Growth 3y CAGR5y CAGR
0.0%
Premium
Premium
Payout Payout 3yPayout 5y
43.9%
Premium
Premium
Yield
BenchmarkDividends
No items found.
Financials Overview
Key metrics over the past few years-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$35.473m
-
1y CAGR-
3y CAGR-
5y CAGREarnings
$107.649m
-
1y CAGR-
3y CAGR-
5y CAGREPS
$3.92
-
1y CAGR-
3y CAGR-
5y CAGRBook Value
$459.695m
$460.583m
Assets$888.610k
Liabilities-
DebtDebt to Assets
0.0%
-
Debt to EBITDAFree Cash Flow
$0.00
-
1y CAGR-
3y CAGR-
5y CAGRFinancial Reports
Earnings and other important metricsNo items found.
Press Releases
Statements and updates from the company